Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 3(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03503357Not ApplicableCompleted

ConsCIOUS2 Study of the Isolated Forearm Technique Commands

Role: collaborator

NCT02521662Phase 3Completed

The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation

Role: collaborator

NCT01791387Phase 2Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Role: lead

NCT00994903Phase 3Completed

Simvastatin in Colorectal Surgery

Role: collaborator

NCT01027455Not ApplicableUnknown

Warm Humid Gas Insufflation for Appendix Removal by Minimally Invasive Surgery Warm Humid Insufflation for Appendix Removal by Minimally Invasive Surgery Trial (WARMIST)

Role: collaborator

NCT00441220Unknown

Cyclophosphamide in Lupus Nephritis

Role: collaborator

All 6 trials loaded